Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (RIVER-PCI) trial (Q45195984)
Jump to navigation
Jump to search
scientific article published on 16 October 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (RIVER-PCI) trial |
scientific article published on 16 October 2013 |
Statements
1 reference
Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (RIVER-PCI) trial (English)
1 reference
Gilles Montalescot
1 reference
E Magnus Ohman
1 reference
Amir Lerman
1 reference
Ramin Farzaneh-Far
1 reference
Ori Ben-Yehuda
1 reference
Gregg W Stone
1 reference
Ehtisham Mahmud
1 reference
Giora Weisz
1 reference
Harvey D White
1 reference
Bernard Debruyne
1 reference
Karen P Alexander
1 reference
Ann Olmsted
1 reference
Gennyne A Walker
1 reference
16 October 2013
1 reference
1 reference
166
1 reference
6
1 reference
953-959.e3
1 reference
Identifiers
1 reference
1 reference